Kilkof Expectorant (Ammonium Chloride Bp, Diphenhydramine Hydrochloride Bp)

Kilkof Expectorant combines an expectorant and an antihistamine to address respiratory tract irritation and allergic inflammation.

• Productive cough: loosens thick mucus and facilitates expectoration.
• Chest congestion: reduces the viscosity of bronchial secretions for easier clearance.
• Allergic rhinitis: alleviates nasal discharge, itching and sneezing associated with allergies.
• Common cold symptoms: eases cough and nasal congestion during viral upper respiratory infections.

• Ammonium chloride acts as a respiratory mucosal irritant, stimulating cough reflexes and increasing the volume of bronchial secretions, which promotes expectoration. Diphenhydramine hydrochloride blocks H1 histamine receptors, diminishing allergic inflammation and providing antitussive and sedative effects. Together, the components enhance mucus clearance while reducing histamine‑mediated airway irritation, supporting symptomatic relief in cough, congestion and allergic rhinitis. The combined action results in improved patient comfort during acute upper respiratory episodes.

Kilkof Expectorant may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Dry mouth: reduced salivary flow causing throat discomfort.
• Drowsiness: sedation or feeling of tiredness.
• Dizziness: light‑headed sensation.
• Nausea: mild stomach upset.
• Blurred vision: temporary visual disturbances.
• Constipation: decreased bowel movements.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with breathing difficulty.
• Cardiac arrhythmia: irregular heart rhythm.
• Hallucinations: visual or auditory disturbances.
• Seizures: convulsive episodes.
• Urinary retention: difficulty emptying the bladder.

When using Kilkof Expectorant, consider the following precautions to ensure safe and effective use.

• Age restrictions: use in children only under medical supervision.
• Glaucoma: avoid in patients with narrow‑angle glaucoma due to anticholinergic effects.
• Asthma: monitor closely as the expectorant may provoke bronchospasm.
• Alcohol and CNS depressants: avoid concurrent use to reduce excessive sedation.
• Prolonged use: limit duration to the shortest period needed for symptom relief.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Kilkof Expectorant can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Alcohol and sedatives: may intensify drowsiness and respiratory depression.
• Other antihistamines: increase risk of anticholinergic side effects.
• Tricyclic antidepressants: enhance sedative effects.
• Opioid analgesics: potentiate central nervous system depression.
• Monoamine oxidase inhibitors: may cause excessive anticholinergic burden.

Moderate Interactions (Monitor Closely)

• CYP2D6 substrates (e.g., metoprolol): diphenhydramine may inhibit metabolism, raising drug levels.
• Antihypertensive agents: additive hypotensive effect possible.
• Antipsychotics: increased sedation risk.